Biostage, Inc.·4

Apr 12, 11:24 AM ET

He Junli 4

4 · Biostage, Inc. · Filed Apr 12, 2023

Insider Transaction Report

Form 4
Period: 2023-04-10
He Junli
DirectorCEO
Transactions
  • Award

    Stock Option (right to buy)

    2023-04-10+732,384732,384 total
    Exercise: $6.08Exp: 2033-04-10Common Stock, par value $0.01 per share (732,384 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-10+488,256488,256 total
    Exercise: $6.08Exp: 2033-04-10Common Stock, par value $0.01 per share (488,256 underlying)
Footnotes (2)
  • [F1]Subject to continued employment or service through the applicable vesting dates, the non-qualified stock option will vest monthly in thirty-six equal monthly installments on each monthly anniversary of April 10, 2023.
  • [F2]Subject to continued employment or service through the applicable vesting dates, up to 488,256 shall vest in two increments, each for 244,128 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary